🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Dry Eye Disease

Phase III Study of OT202 in Treating Moderate to Severe Dry Eye NCT07740564Phase 349 sites📍 Bengbu📍 Hefei📍 Beijing Ocumension Therapeutics (Suzhou) Co., Ltd · Tests: OT202 conc 1%, Placebo BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy Kelulut Honey for Allergic Conjunctivitis and Dry Eye Symptoms NCT07273747NA1 site📍 Kota Bharu Universiti Sains Malaysia · Tests: Kelulut Honey 60 g Oral Supplement, Kelulut Honey 120 g Oral Supplement, Honey-Flavoured Zero-Calorie Syrup (Placebo) AVIGA3 (Cohort 2.0) NCT07255859NA1 site📍 Singapore Tan Tock Seng Hospital · Tests: Amsler Grid, AVIGA Dose-Finding Study of HUC1-394 in Participants With Dry Eye Disease NCT07656688Phase 21 site📍 Seoul Huons Co., Ltd. · Tests: HUC1-394, Placebo Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease NCT07676084Phase 41 site📍 Andover Andover Research Eye Institute · Tests: Preservative Free Polyethylene glycol 400 0.25%, Propylene Glycol (0.6%), Carboxymethylcellulose sodium 0.5%, Glycerin … Ocular Microbiome and Immune System in Dry Eyes NCT04658238n/a1 site📍 Bern Insel Gruppe AG, University Hospital Bern · Tests: Ocular microbiome, Ocular immune system A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases NCT07284797Phase 11 site📍 Melbourne Xencor, Inc. · Tests: XmAb657 Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration NCT04339764Phase 1, Phase 22 sites📍 Baltimore📍 Bethesda National Eye Institute (NEI) · Tests: iPSC-derived RPE/PLGA transplantation A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease NCT07737743Phase 225 sites📍 Clearwater📍 Tampa📍 Chicago Novartis Pharmaceuticals · Tests: DDY391, Placebo A Study to Evaluate the Performance and Safety of Artelac® Complete MDO® Versus VISMED® MULTI Eye Drops in the Management of Moderate to Severe Dry Eye Disease NCT07593885NA12 sites📍 Freiburg im Breisgau📍 Heidelberg📍 Tübingen Dr. Gerhard Mann chem.-pharm. Fabrik GmbH · Tests: Artelac® Complete MDO® Eye Drops, VISMED® MULTI Eye Drops Evaluation of a Novel Ocular Lubricating Eye Drop NCT07593404NA1 site📍 Waterloo Pleryon Therapeutics (Hangzhou) Limited · Tests: Part 2 ABR2 At least twice a day for 28 days, Part 1: ABR2 single dose in one eye Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases NCT06842316n/a1 site📍 Orléans Centre Hospitalier Régional d'Orléans · Tests: 1 blood sample, 40 mL (collection during a blood test, part of the standard of care for this disease) The Pathogenesis and Natural History of Sjogren's Disease NCT01425892n/a1 site📍 Bethesda National Institute of Dental and Craniofacial Research (NID… Efficacy of Lycium Barbarum Polysaccharide in Dry Eye Disease Management NCT07842536NA1 site📍 Hong Kong The Hong Kong Polytechnic University · Tests: Lycium Barbarum Polysaccharide Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease NCT06805448Phase 1, Phase 21 site📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: MSC, Saline Water (Control) Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface NCT04198740n/a2 sites📍 Montreal📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Tear sample collection via Schirmer strip and subsequent analysis by mass spectrometry Association Between Periodontitis and Dry Eye Disease: A Cross-Sectional Study NCT07873697n/a1 site📍 Sulaymaniyah University of Sulaimani Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study NCT03921931NA1 site📍 Vienna Medical University of Vienna · Tests: White light stimulation Human Umbilical Cord Mesenchymal Stem Cell-derived Small Extracellular Vesicles for the Treatment of Dry Eye Disease NCT07623382EARLY Phase 11 site📍 Xiamen The First Affiliated Hospital of Xiamen University · Tests: Human umbilical cord mesenchymal stem cell-derived small extracellular vesicle (sEV) eye drops. (CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000 NCT07680244NA6 sites📍 Tucson📍 Mountain View📍 San Francisco Carl Zeiss Meditec-Dublin CoCe · Tests: PathFinder 1.0 on CIRRUS HD-OCT The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment NCT06830551NA1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: administration cord blood based eye drops, standardized to the deliver BDNF. Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease NCT07843381n/a1 site📍 Beijing Peking University People's Hospital · Tests: Telitacicept 160mg, Conventional treatment Clinical Study of BCT301 Cell Injection Therapy for Refractory Autoimmune Diseases NCT07301164EARLY Phase 11 site📍 Beijing Peking University Third Hospital · Tests: BCT301 Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3% (FBV_01) vs Hyaluronic Acid 0.3% in Subjects in the Treatment From Moderate to Severe DED NCT07412860NA2 sites📍 Cagliari📍 Catanzaro FB Vision S.p.A · Tests: FBV_01, HYLO-VISION® SafeDrop® Gel Telemedicine Evaluation of Dry Eye Disease Using a Portable Automatic Ocular Surface Imaging Device (PAOSID) NCT06984549n/a1 site📍 Wenzhou Chen Wei · Tests: DED diagnosis using PAOSID, DED diagnosis using slit lamp Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders NCT07180537NA1 site📍 Iowa City Terry L. Wahls · Tests: Creating Health Online Course, Delayed access to Creating Health Online Course TREATMENT OF VAGINAL DRYNESS IN SJÖGREN'S DISEASE WITH CO2-LASER VERSUS TOPICAL PROMESTRIENE NCT07153276Phase 41 site📍 São Paulo University of Sao Paulo General Hospital · Tests: Fractional CO2 laser (vaginal), Promestriene Vaginal Protecting the Eyes of Gamers With Lubricating Eyedrops NCT06163989NA1 site📍 Birmingham Aston University · Tests: TheaLoz Duo Eyedrop Ocular Surface Health and Tear Film Stability With a Nasal Spray Dry Eye Treatment NCT07606625Phase 41 site📍 Berkeley University of California, Berkeley · Tests: Varenicline 0.03Mg/Spray Nasal Soln
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy